LNTH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LNTH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Lantheus Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was $11.91.
During the past 12 months, Lantheus Holdings's average Book Value per Share Growth Rate was 79.80% per year. During the past 3 years, the average Book Value per Share Growth Rate was 15.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was 39.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Lantheus Holdings was 131.80% per year. The lowest was 13.90% per year. And the median was 35.20% per year.
For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Lantheus Holdings's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
Lantheus Holdings (NAS:LNTH) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Thank you for viewing the detailed overview of Lantheus Holdings's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Andrea Sabens | officer: Chief Accounting Officer | C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862 |
Marshall Robert J. Jr. | officer: CFO and Treasurer | C/O LANTHEUS MEDICAL IMAGING, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862 |
Paul Blanchfield | officer: Chief Commercial Officer | C/O LANTHEUS HOLDINGS, INC., 331, NORTH BILLERICA MA 01862 |
Mary Anne Heino | director, officer: CEO and President | C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA NY 01862 |
Daniel Niedzwiecki | officer: See Remarks | C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862 |
Minnie Baylor-henry | director | C/O SCPHARMACUETICALS, INC., 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA 01803 |
Etienne Montagut | officer: See Remarks | C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862 |
Sam R Leno | director | C/O BOSTON SCIENTIFIC CORPORATION, ONE BOSTON SCIENTIFIC PLACE, NATICK MA 01760 |
Brian A Markison | director | 501 FIFTH STREET, BRISTOL TN 37620 |
Jean-claude Provost | officer: Chief Medical Officer | C/O LANTHEUS HOLDINGS, INC., 201 BURLINGTON RD, SOUTH BUILDING, BEDFORD MA 01730 |
Julie Mchugh | director | C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON MA 02110 |
Gerard Ber | director | C/O Y-MABS THERAPEUTICS, INC., 230 PARK AVENUE, 33RD FLOOR, NEW YORK NY 10169 |
Carol Walker | officer: Senior Vice President, Quality | C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862 |
Ying Vivian Yao | officer: Chief Human Resources Officer | C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862 |
John J. Bolla | director | C/O LANTHEUS MEDICAL IMAGING, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862 |
From GuruFocus
By sperokesalga sperokesalga • 02-16-2023
By Marketwired • 08-03-2023
By Marketwired • 10-19-2023
By Nathan Aisenstadt • 12-17-2023
By Marketwired • 07-20-2023
By GuruFocus Research • 12-11-2023
By Value_Insider Value_Insider • 12-12-2022
By Stock market mentor Stock market mentor • 02-06-2023
By Marketwired • 08-31-2023
By Value_Insider Value_Insider • 12-06-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.